UCSF has joined a growing network devoted to combating primary hyperoxaluria. As part of this initiative, patients can now ...

We can see that Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) does use debt in its business. But is this debt a concern to shareholders? Debt assists a business until the business has trouble paying it ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Buying $100 In ALNY: If an investor had bought $100 of ALNY stock 10 years ago, it would be worth $385.28 today based on a price of $433.41 for ALNY at the time of writing.

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca ...

Detailed price information for Centessa Pharmaceuticals Plc ADR (CNTA-Q) from The Globe and Mail including charting and trades.

Alnylam Pharmaceuticals (($ALNY)) announced an update on their ongoing clinical study. Alnylam Pharmaceuticals is conducting a study titled ‘An ...

Brad Marshall, global head of private credit strategies at Blackstone, says he owes his family and career to this asset class ...

With ongoing clinical trials and promising early data, tegoprubart may soon redefine the standard of care in transplantation ...

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...